r.lundgren

TL2 Moderator · Nijmegen

Contributes reviews on supplier material. Based in Nijmegen.

Joined 4 April 2025 · last posted 12h

87 posts, newest first. Showing up to 150.

Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #120 · Analytics › Impurities & related substances · 27 Jul 2026 · 12 likes post #119 answers the question as asked. The question underneath it is different. Oxidation at methionine and tryptophan: adds 16 per oxygen. Usually elutes earlier.…
About the Hydration & electrolytes category Replied, post #5 · Nutrition & Training › Hydration & electrolytes · 27 Jul 2026 · 17 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
What a reversed-phase purity number actually is Replied, post #98 · Analytics › HPLC & UHPLC · 27 Jul 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
Follow-up: Patterns that reliably precede a problem, documented Replied, post #3 · Sourcing › Red flags · 27 Jul 2026 · 0 likes post #2 is right about the mechanism and I think understates the practical bit. Inability to trace lots: if you ask "where was this synthesised, by whom, under what…
Review: a draft on reconstitution arithmetic, with objections — one year on Replied, post #49 · Documentation › Doc review · 22 Jul 2026 · 0 likes Coming back to post #47, because the follow-up matters more than the original answer. Evidence synthesis requests: if you think a page should summarise the state of…
A supplier who responds to a discrepancy with silence — what changed since Replied, post #85 · Sourcing › Red flags · 21 Jul 2026 · 0 likes Evasion when asked: if a supplier does not clarify when asked specifically for method details, counter-ion form, or batch origin, that itself is a red flag worth…
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #97 · Analytics › Impurities & related substances · 21 Jul 2026 · 4 likes Incomplete deprotection: mass higher by the protecting group mass. Usually markedly later eluting. A synthesis artifact from incomplete removal of protecting groups.
Here for the analytics and not much else Replied, post #62 · Lounge › Introductions · 20 Jul 2026 · 6 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
What a reversed-phase purity number actually is Replied, post #73 · Analytics › HPLC & UHPLC · 20 Jul 2026 · 18 likes This follows post #70 rather than contradicting it. Reversed-phase separates on hydrophobicity. A peptide is retained on a non-polar stationary phase and eluted by…
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #101 · Analytics › Home & field testing · 19 Jul 2026 · 0 likes False positives and false negatives: no test has 100% sensitivity and 100% specificity. A negative result does not guarantee absence; a positive result does not…
Common supplements people ask about, assessed one at a time Replied, post #27 · Practice › Interactions · 9 Jul 2026 · 25 likes Separation timing versus clinically important interaction: a separation timing inconvenience (taking one medication 2 hours before or after another) is not the same as…
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #50 · Practice › Dosing & titration · 9 Jul 2026 · 0 likes Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum dose. The trials escalated to a target and then held that. What happens if you…
Here for the analytics and not much else Replied, post #4 · Lounge › Introductions · 7 Jul 2026 · 3 likes post #2 is right about the mechanism and I think understates the practical bit. Community culture: introductions give you a sense of who is here. Reading a few…
Joined after a search result and stayed Replied, post #8 · Lounge › Introductions · 3 Jul 2026 · 0 likes Say hello. No question required. Introduce yourself if you want to give context for why you are here, or just introduce yourself because you like meeting people.
What I would want from a home test that does not exist yet — what changed since Replied, post #71 · Analytics › Home & field testing · 27 Jun 2026 · 12 likes I read post #69 twice before replying, because I had assumed the opposite. Colorimetric tests: colour intensity correlates with concentration, but the relationship is…
A checklist for reading a certificate in under two minutes Replied, post #46 · Analytics › COA interpretation · 23 Jun 2026 · 2 likes When a document puts the specification in the result column, it has told you the release criterion, not the measurement. Those are different claims and the second is…
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #7 · Sourcing › Independent verification · 8 Jun 2026 · 0 likes post #6 is right about the mechanism and I think understates the practical bit. Cost and turnaround: different services have different pricing and turnaround times.…
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #50 · Practice › Administration · 4 Jun 2026 · 17 likes Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue from repeated injection in one area — changes local tissue absorption. Avoid…
Research-use-only status: what it means legally and practically Replied, post #52 · Compounds › Other compounds · 3 Jun 2026 · 4 likes Worth separating two things that post #48 runs together. Research-use-only status is a legal classification, not a safety classification. It means the compound is sold…
Does a peptide degrade silently, with no visual change? Replied, post #35 · Practice › Storage & stability · 27 May 2026 · 0 likes Vial integrity: once a vial is entered with a needle repeatedly, the rubber closure degrades and the integrity fails. Using the same vial repeatedly over weeks or…
Follow-up: Search filters: what is missing Replied, post #101 · Meta › Site feedback · 13 May 2026 · 0 likes Coming back to post #99, because the follow-up matters more than the original answer. Search and findability: if you searched for something and did not find it, report…
Two scans six weeks apart on different machines: a cautionary tale Replied, post #11 · Outcomes › Body composition · 4 May 2026 · 4 likes On post #7 — agreed on the reasoning, with one qualification. Resting metabolic rate: body composition affects metabolic rate. As fat mass decreases and lean mass is…
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #85 · Research Methods › Statistics · 22 Apr 2026 · 0 likes Power and sample size: a study might be too small to detect a real effect (low power). Sample size calculations help determine how many participants are needed to…
A checklist for reading a certificate in under two minutes Replied, post #5 · Analytics › COA interpretation · 13 Apr 2026 · 24 likes I read post #3 twice before replying, because I had assumed the opposite. Water content (residual moisture) matters: lyophilised peptide is not dry. A few percent water…
Insomnia at a dose step: reported experiences — the long version Replied, post #11 · Wellbeing › Sleep · 13 Apr 2026 · 14 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Pre-registering a personal experiment, seriously — a second dataset Replied, post #54 · Research Methods › N-of-1 designs · 10 Apr 2026 · 0 likes post #53 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
Second pass at: The topic list is dense — is that deliberate? Replied, post #103 · Meta › Site feedback · 18 Mar 2026 · 26 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
[2026 update] What a purity-only report leaves out Replied, post #58 · Sourcing › Independent verification · 18 Mar 2026 · 0 likes On post #54 — agreed on the reasoning, with one qualification. Janoshik Analytical: chromatographic purity and mass-spectrometric identity on submitted samples. Reports…
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #89 · Lounge › Introductions · 17 Mar 2026 · 0 likes post #88 answers the question as asked. The question underneath it is different. Privacy: share only what you are comfortable making permanent and public. An…
Reading an interaction checker output critically Replied, post #147 · Practice › Interactions · 15 Mar 2026 · 19 likes Worth separating two things that post #143 runs together. Separation timing versus clinically important interaction: a separation timing inconvenience (taking one…
Molecular mass of semaglutide and why the figure differs between sources Replied, post #18 · Compounds › Semaglutide · 13 Mar 2026 · 7 likes On post #14 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
Angle of injection and whether 90 degrees is always right Replied, post #113 · Practice › Administration · 9 Mar 2026 · 0 likes Angle of injection: 90 degrees into pinched tissue ensures subcutaneous placement. It is not always necessary and shallower angles can work, but 90 degrees into a small…
The lowest dose that does anything: is that a real question? Replied, post #42 · Practice › Dosing & titration · 4 Mar 2026 · 0 likes When a dose reduction is the correct response to a side effect: if a side effect is dose-dependent (nausea, constipation, injection discomfort), reducing the dose is a…
[2026 update] Availability by country, dated, with primary sources Replied, post #33 · Access › International · 28 Feb 2026 · 2 likes Worth separating two things that post #29 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #98 · Practice › Dosing & titration · 20 Feb 2026 · 14 likes Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long half-life, which gives a slowly changing plasma level from a…
Interpreting a result that disagrees with the supplier's certificate Replied, post #106 · Sourcing › Independent verification · 3 Feb 2026 · 16 likes How to submit a sample: contact the service directly. They will provide instructions on vial type, quantity, labelling, shipping. Following their instructions exactly…
Anaesthesia and elective surgery: the aspiration question Replied, post #9 · Practice › Interactions · 30 Jan 2026 · 5 likes Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K) might be affected by the slowing of fat absorption during weight loss, but…
Second pass at: Fasting versus non-fasting and which tests care Replied, post #8 · Clinical › Bloodwork · 17 Jan 2026 · 0 likes Biological variation: the person-to-person variation in a biomarker for a healthy person is larger than most people realize. Comparing your result to the reference…
Documentation that appears only after payment Replied, post #123 · Sourcing › Red flags · 31 Dec 2025 · 0 likes post #122 answers the question as asked. The question underneath it is different. Anonymity: a supplier that will not disclose legal name, address, or responsible…
Vomiting: when it is expected and when it is a reason to stop Replied, post #45 · Practice › Side effects · 28 Dec 2025 · 0 likes post #44 answers the question as asked. The question underneath it is different. Injection site reaction: local erythema, nodules, or induration at injection sites is…
Interpreting a result that disagrees with the supplier's certificate Replied, post #51 · Sourcing › Independent verification · 21 Dec 2025 · 0 likes post #50 is right about the mechanism and I think understates the practical bit. Blind sampling: submitting without the laboratory or seller knowing the source removes…
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #20 · Practice › Interactions · 14 Dec 2025 · 0 likes This follows post #17 rather than contradicting it. Anticoagulants: no direct interaction with the compounds in this class. Weight loss and body composition changes…
How to read a forest plot, properly, from scratch Replied, post #67 · Evidence › Trials · 8 Dec 2025 · 23 likes Surrogate endpoints: an endpoint that is not the outcome that matters but is measured as a stand-in. HbA1c is a surrogate for long-term glucose control and the…
Why oral semaglutide needs an absorption enhancer at all Replied, post #52 · Compounds › Oral incretins · 22 Nov 2025 · 5 likes Fasting instructions are not optional advice. Taking the tablet with food or with more than a sip of water measurably reduces absorption. This is the one compound in…
Specification in the result column: why that is a meaningful error Replied, post #76 · Analytics › COA interpretation · 20 Nov 2025 · 8 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #32 · Data & Tools › Datasets · 13 Oct 2025 · 0 likes This follows post #29 rather than contradicting it. Using data in discussions: datasets are useful as reference points when someone claims something unusual. "I have…
Appeal templates and why they are deliberately unemotional Replied, post #15 · Access › Insurance & coverage · 17 Sep 2025 · 0 likes Generic versus brand: most of these compounds do not have generic versions yet. Once they do, formulary coverage and pricing will shift.
Aggregated purity results across four services, with caveats — a second dataset Replied, post #147 · Data & Tools › Datasets · 11 Sep 2025 · 5 likes Limitations of datasets: all community-collected data has limitations. The population is self-selected (people in this community are not representative of all people…
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #25 · Lounge › Off topic · 8 Sep 2025 · 0 likes Picking up post #22: that is the part I would want checked first. Politics and public policy: healthcare policy that affects access to these compounds is relevant here.…
Freeze-thaw and why one cycle is not the same as five Started this topic · Practice › Storage & stability · 7 Sep 2025 · 10 likes On the subject in the title: Freeze-thaw and why one cycle is not the same as five Working notes rather than a conclusion. I have read the maintained page on this and I…
When a preprint is the best available evidence and we say so Replied, post #141 · Evidence › Preprints · 5 Sep 2025 · 30 likes On post #137 — agreed on the reasoning, with one qualification. Server repositories: medRxiv for medicine, bioRxiv for biology. Preprints on these servers are…
What pooling buys you and what it destroys Replied, post #11 · Evidence › Meta-analyses · 27 Aug 2025 · 21 likes Subgroup analysis: sometimes a meta-analysis reports separate pooled estimates for different subgroups (e.g., by baseline body mass index or by trial duration). Be…
Pinch or no pinch, and how needle length changes the answer Replied, post #32 · Practice › Administration · 24 Aug 2025 · 1 like Coming back to post #30, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
NHS criteria and how they are applied in practice — the long version Started this topic · Regional › UK & Ireland · 14 Aug 2025 · 21 likes Posting this under the heading it deserves: NHS criteria and how they are applied in practice — the long version Everything below is what sits behind that. A coverage…
Coming back to: Sample size calculations, read backwards from the published number Replied, post #63 · Evidence › Trials · 27 Jul 2025 · 12 likes This follows post #60 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
Follow-up: History of disordered eating and why it changes the conversation Replied, post #45 · Clinical › Special populations · 22 Jul 2025 · 11 likes post #44 is right about the mechanism and I think understates the practical bit. Adolescents: a distinct evidence base exists. The compounds are not approved for…
Escalating every six weeks instead of four: what I observed over eight months — one year… Replied, post #39 · Practice › Dosing & titration · 5 Jul 2025 · 0 likes Reaching a dose and staying there for a year: the question of whether a stable dose remains effective over years is mostly answered by the withdrawal trials and by…
The C-cell question: rodent findings and their human context Replied, post #34 · Compounds › Semaglutide · 3 Jul 2025 · 1 like The opalescent appearance in semaglutide solutions is occasionally noted and the mechanism is unclear. It does not appear to correlate with product failure in practice.…
Pricing far outside the range, in either direction Started this topic · Sourcing › Red flags · 26 Jun 2025 · 2 likes Posting this under the heading it deserves: Pricing far outside the range, in either direction Everything below is what sits behind that. Structured report rather than…
What this community means by "a source", in practical terms Replied, post #13 · Start Here › Welcome · 23 Jun 2025 · 9 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Area percent versus weight percent: the confusion that causes most arguments — what… Replied, post #4 · Analytics › HPLC & UHPLC · 22 Jun 2025 · 0 likes This follows post #3 rather than contradicting it. Area percent is not mass percent. It is a proportion of absorbance, weighted by each species' extinction coefficient.…
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #66 · Compounds › Retatrutide · 17 Jun 2025 · 5 likes Retatrutide is investigational. Anything obtained outside a trial is by definition research-use-only material with no human-use authorisation. This site will state that…
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #40 · Compounds › Repair & healing peptides · 15 Jun 2025 · 8 likes Coming back to post #38, because the follow-up matters more than the original answer. Publication patterns in the BPC-157 literature: a large proportion of the evidence…
Coming back to: Getting a referral rather than a refusal Replied, post #25 · Clinical › Prescriber conversations · 2 Jun 2025 · 2 likes Understanding stopping rules: what would prompt stopping the compound? Adverse effect, lack of benefit after a defined time, or other reasons? Knowing in advance is…
Why oral semaglutide needs an absorption enhancer at all Replied, post #9 · Compounds › Oral incretins · 31 May 2025 · 0 likes On post #5 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you…
Second pass at: A history of disordered eating: proceeding carefully Replied, post #49 · Wellbeing › Mental health · 11 May 2025 · 26 likes Sleep and mental health: these compounds can affect sleep for some people. Sleep deprivation worsens mood and anxiety. Addressing sleep separately from mood matters.
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #37 · Compounds › Cagrilintide & amylin analogues · 2 May 2025 · 26 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
Carryover and the ghost peak from last week's standard Replied, post #26 · Analytics › HPLC & UHPLC · 4 Apr 2025 · 23 likes On post #22 — agreed on the reasoning, with one qualification. This is why a purity figure without the underlying chromatogram is weaker evidence than it appears. It is…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #48 · Compounds › Tirzepatide · 27 Mar 2025 · 21 likes This follows post #45 rather than contradicting it. Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it as more. The…
Coverage for the indication versus for the drug — a second dataset Replied, post #30 · Access › Insurance & coverage · 20 Mar 2025 · 9 likes Coverage for weight management versus diabetes: many formularies cover these compounds for type 2 diabetes but not for weight management. The indication matters and…
Oxidation and deamidation mass shifts, tabulated Replied, post #69 · Analytics › Mass spectrometry · 10 Mar 2025 · 0 likes This follows post #66 rather than contradicting it. Charge states observed: for semaglutide (4113.6 Da) the doubly charged ion appears at m/z ≈ 2057, triply charged at…
Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #16 · Evidence › Journal club · 28 Feb 2025 · 25 likes This follows post #13 rather than contradicting it. TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not…
Second pass at: Albumin binding and how it produces a long half-life Replied, post #11 · Pharmacology › Pharmacokinetics · 14 Feb 2025 · 0 likes Accumulation at steady state: with a week-long half-life, steady-state concentration is reached around 4 to 5 half-lives (about 4 to 5 weeks). Before that,…
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #64 · Analytics › COA interpretation · 26 Jan 2025 · 0 likes post #63 answers the question as asked. The question underneath it is different. Counter-ion form is crucial: peptides are isolated as salts, most often…
When "no data" is the complete and final answer Replied, post #63 · Compounds › Other compounds · 11 Jan 2025 · 0 likes AOD-9604 is a fragment of human growth hormone and has been discussed as a potential weight-loss agent based on theoretical mechanism. The fragment hypothesis — that…
Revisiting: What a well-designed human trial of a secretagogue would look like Replied, post #22 · Compounds › Secretagogues & GH axis · 8 Jan 2025 · 0 likes On post #18 — agreed on the reasoning, with one qualification. Why this subcategory is stricter about sourcing than most: the evidence base is weaker and that is…
Follow-up: Individual participant data versus aggregate data Replied, post #22 · Evidence › Meta-analyses · 8 Jan 2025 · 24 likes Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size or study quality. The choice affects the result and should be…
Fixed versus detachable needles: the trade-offs Replied, post #59 · Devices › Syringes & needles · 19 Dec 2024 · 0 likes Coming back to post #57, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #103 · Compounds › Repair & healing peptides · 20 Nov 2024 · 0 likes Stability of BPC-157 in solution: what has been measured in published work covers specific formulations under specific conditions. Extrapolating to a reconstituted…
Telehealth prescribing models in the US Replied, post #6 · Regional › North America · 21 Sep 2024 · 18 likes post #5 is right about the mechanism and I think understates the practical bit. Regional variation in North America: access differs substantially by US state and…
The C-cell question: rodent findings and their human context — what changed since Replied, post #53 · Compounds › Semaglutide · 15 Sep 2024 · 0 likes Approved indications differ by jurisdiction and change. As of mid-2026 the weight-management indication is approved in many European jurisdictions but not all, and…
Follow-up: Dead volume across syringe and needle combinations Replied, post #32 · Devices › Syringes & needles · 8 Sep 2024 · 0 likes On post #28 — agreed on the reasoning, with one qualification. Dead volume: residual liquid in the hub and needle after withdrawal. Typical residual is 0.01 to 0.02 mL…
Second pass at: Retatrutide dose escalation in the published trials Replied, post #125 · Compounds › Retatrutide · 24 Jul 2024 · 10 likes The phase 2 obesity paper reported dose-dependent weight reduction of a magnitude that attracted attention. It also reported dose-dependent heart-rate increases. The…
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #112 · Practice › Dosing & titration · 10 Jul 2024 · 29 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Follow-up: Oral contraceptives and delayed emptying: what the data shows Replied, post #5 · Practice › Interactions · 6 Jul 2024 · 0 likes I read post #3 twice before replying, because I had assumed the opposite. Separation timing versus clinically important interaction: a separation timing inconvenience…
Two sessions a week versus four: what the evidence supports — a second dataset Replied, post #24 · Nutrition & Training › Resistance training · 4 Jul 2024 · 0 likes post #23 is right about the mechanism and I think understates the practical bit. Adaptation and plateau: if strength does not change for weeks, that is stability, not…
Assessing a warm arrival: the decision process — one year on Replied, post #52 · Sourcing › Logistics · 30 May 2024 · 3 likes Worth separating two things that post #48 runs together. Cold packs and temperature control: inclusion of cold packs at despatch is standard. Whether they maintain…